The estimated Net Worth of Jennifer Bealer is at least $6.17 Million dollars as of 18 November 2021. Ms Bealer owns over 6,876 units of Progyny Inc stock worth over $1,747,087 and over the last 5 years she sold PGNY stock worth over $3,927,080. In addition, she makes $499,120 as Exec. VP and Gen. Counsel & Sec. at Progyny Inc.
Ms has made over 29 trades of the Progyny Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently she exercised 6,876 units of PGNY stock worth $6,257 on 18 November 2021.
The largest trade she's ever made was exercising 50,023 units of Progyny Inc stock on 11 August 2020 worth over $198,091. On average, Ms trades about 9,658 units every 23 days since 2019. As of 18 November 2021 she still owns at least 76,292 units of Progyny Inc stock.
You can see the complete history of Ms Bealer stock trades at the bottom of the page.
Jennifer Bealer is the Exec. VP, Gen. Counsel & Sec. at Progyny Inc.
As the Exec. VP and Gen. Counsel & Sec. of Progyny Inc, the total compensation of Ms Bealer at Progyny Inc is $499,120. There are 5 executives at Progyny Inc getting paid more, with David Schlanger having the highest compensation of $4,964,200.
Ms Bealer is 40, she's been the Exec. VP and Gen. Counsel & Sec. of Progyny Inc since . There are 15 older and 1 younger executives at Progyny Inc. The oldest executive at Progyny Inc is Norman Payson, 72, who is the Independent Director.
Jennifer's mailing address filed with the SEC is C/O PROGYNY, INC., 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018.
Over the last 5 years, insiders at Progyny Inc have traded over $949,717,514 worth of Progyny Inc stock and bought 76,923 units worth $999,999 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Plc Gsk, and Gp A, Llcbonderman Davidcou.... On average, Progyny Inc executives and independent directors trade stock every 4 days with the average trade being worth of $2,005,422. The most recent stock trade was executed by Michael E Sturmer on 16 July 2024, trading 9,030 units of PGNY stock currently worth $270,900.
progyny is the leading fertility benefits company that combines service, science, technology and data to provide fertility solutions for self-insured employers. progyny’s approach offers members a comprehensive value based treatment plan that is based on the latest medical science and technology. the benefit plans are designed to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. progyny supports all fertility solutions to include ivf, iui, embryo banking, egg freezing, adoption and surrogacy.
Progyny Inc executives and other stock owners filed with the SEC include: